Association of polymorphism in glutathione S-transferase loci with susceptibility and outcome in rheumatoid arthritis: comparison with the shared epitope

被引:69
作者
Mattey, DL
Hassell, AB
Plant, M
Dawes, PT
Ollier, WR
Jones, PW
Fryer, AA
Alldersea, JE
Strange, RC
机构
[1] Haywood Hosp, Staffordshire Rheumatol Ctr, Stoke On Trent ST6 7AG, Staffs, England
[2] Univ Manchester, ARC Epidemiol Res Unit, Manchester, Lancs, England
[3] Univ Keele, Dept Math, Keele ST5 5BG, Staffs, England
[4] Keele Univ, N Staffordshire Hosp, Clin Biochem Res Lab, Postgrad Med Sch, Stoke On Trent, Staffs, England
关键词
D O I
10.1136/ard.58.3.164
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective-To determine whether glutathione S-transferase GSTM1, GSTM3, GSTT1, and GSTP1 genotypes influence susceptibility or outcome in rheumatoid arthritis (RA). Methods-277 RA patients were compared with 577 controls to examine any associations between GST genotypes and susceptibility to RA. The effect of genotypes on outcome (Larsen and functional scores) and time integrated acute phase responses (erythrocyte sedimentation rate and C reactive protein) was assessed in 122 patients with disease duration of 5-10 years. GST and HLA-DRB1 genotypes were determined using polymerase chain reaction based assays. Data were analysed using multiple regression analysis with correction for age, sex, disease duration, and the DRB1 associated shared epitope (SE) and rheumatoid factor (RF) positivity where appropriate. Results-The GSTM1*A/*B genotype was less common in RA cases (3 of 276) than in controls (22 of 591) (exact p=0.047), though significance was lost when adjustment was made for multiple comparisons. The Larsen score was higher (p=0.039) in the GSTM1 null patients (89.9) than those with other GSTM1 genotypes (74.7), and this was independent of the SE. Again, correction for multiple testing resulted in loss of significance. The difference in Larsen scores between patients homozygous or negative for the SE (87.9 v 74.3) was similar to that between GSTM1 null and non-null patients. No associations between GSTM3 or GSTT1 genotypes and disease markers were identified although the association between GSTP1*B/*B and Larsen score approached significance (p=0.096). Conclusion-It is proposed that certain GSTs may influence susceptibility and radiological progression in RA and that this is independent of the effect of the HLA-DRB1 associated SE. The mechanism for this effect is presumed to be because of differences in the ability of various GST enzymes to utilise the cytotoxic products of oxidant stress. Although significance was lost after correction for multiple testing, the data indicate that further studies may be of value in RA to determine the influence of the GST and other genes involved in cellular protection against oxidative stress.
引用
收藏
页码:164 / 168
页数:5
相关论文
共 25 条
  • [1] Adjusting for multiple testing when reporting research results: The Bonferroni vs Holm methods
    Aickin, M
    Gensler, H
    [J]. AMERICAN JOURNAL OF PUBLIC HEALTH, 1996, 86 (05) : 726 - 728
  • [2] AliOsman F, 1997, J BIOL CHEM, V272, P10004
  • [3] HYPOXIC-REPERFUSION INJURY IN THE INFLAMED HUMAN JOINT
    BLAKE, DR
    MERRY, P
    UNSWORTH, J
    KIDD, BL
    OUTHWAITE, JM
    BALLARD, R
    MORRIS, CJ
    GRAY, L
    LUNEC, J
    [J]. LANCET, 1989, 1 (8633) : 289 - 293
  • [4] MEASUREMENT OF PATIENT OUTCOME IN ARTHRITIS
    FRIES, JF
    SPITZ, P
    KRAINES, RG
    HOLMAN, HR
    [J]. ARTHRITIS AND RHEUMATISM, 1980, 23 (02): : 137 - 145
  • [5] GAO X, 1990, ARTHRITIS RHEUM, V30, P1205
  • [6] THE SHARED EPITOPE HYPOTHESIS - AN APPROACH TO UNDERSTANDING THE MOLECULAR-GENETICS OF SUSCEPTIBILITY TO RHEUMATOID-ARTHRITIS
    GREGERSEN, PK
    SILVER, J
    WINCHESTER, RJ
    [J]. ARTHRITIS AND RHEUMATISM, 1987, 30 (11): : 1205 - 1213
  • [7] Identification of genetic polymorphisms at the glutathione S-transferase Pi locus and association with susceptibility to bladder, testicular and prostate cancer
    Harries, LW
    Stubbins, MJ
    Forman, D
    Howard, GCW
    Wolf, CR
    [J]. CARCINOGENESIS, 1997, 18 (04) : 641 - 644
  • [8] HASSELL AB, 1993, Q J MED, V86, P601
  • [9] HOLM S, 1979, SCAND J STAT, V6, P65
  • [10] JAWAHEER D, 1993, EUR J IMMUNOGENET, V20, P279